ClinicalTrials.Veeva

Menu
R

Red Oak Psychiatry Associates | Houston, TX

Research site
(Unclaimed)

Site insights

Top conditions

Top treatments

Cariprazine
PRC-063
SPD489
SHP465
Fluoxetine
Aticaprant
BMS-820836
L1-79
Levomilnacipran
Seltorexant

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

3 of 19 total trials

A Study of Aticaprant 10 mg as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy and Long-term Extension Treatment With Aticaprant (VENTURA-7)

The purpose of this study is to evaluate how well aticaprant works as compared with placebo when given along with an antidepressant therapy in improv...

Enrolling
Anhedonia
Depressive Disorder, Major
Drug: Aticaprant
Other: Placebo

Bipolar disorder is a severe chronic mood disorder that affects up to 4% of the adult population and 1.8% of the pediatric population in the United S...

Enrolling
Bipolar I Disorder
Depression
Drug: Placebo
Drug: Cariprazine

The purpose of this study is to evaluate the long-term safety and tolerability of cariprazine in the treatment of pediatric participants with schizop...

Active, not recruiting
Bipolar I Disorder
Schizophrenia
Drug: Cariprazine Flexible Dose

Trial sponsors

AbbVie logo
R
Shire logo
Janssen (J&J Innovative Medicine) logo
Bristol-Myers Squibb (BMS) logo
Forest Laboratories logo
N
N
S
S

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems